Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,452
Closed -$257K 429
2025
Q4
$257K Hold
3,452
﹤0.01% 362
2025
Q3
$233K Buy
3,452
+5
+0.1% +$332 ﹤0.01% 374
2025
Q2
$225K Sell
3,447
-351
-9% -$21K ﹤0.01% 356
2025
Q1
$235K Sell
3,798
-3
-0.1% -$199 0.01% 344
2024
Q4
$274K Buy
3,801
+7
+0.2% +$547 0.01% 344
2024
Q3
$309K Hold
3,794
0.01% 340
2024
Q2
$282K Hold
3,794
0.01% 312
2024
Q1
$296K Hold
3,794
0.01% 319
2023
Q4
$271K Hold
3,794
0.02% 178
2023
Q3
$263K Hold
3,794
0.02% 177
2023
Q2
$307K Hold
3,794
0.03% 181
2023
Q1
$306K Hold
3,794
0.03% 184
2022
Q4
$284K Hold
3,794
0.03% 184
2022
Q3
$245K Hold
3,794
0.02% 172
2022
Q2
$263K Hold
3,794
0.02% 183
2022
Q1
$291K Hold
3,794
0.02% 185
2021
Q4
$290K Hold
3,794
0.02% 187
2021
Q3
$280K Sell
3,794
-239
-6% -$17.9K 0.02% 197
2021
Q2
$269K Sell
4,033
-690
-15% -$46.1K 0.02% 207
2021
Q1
$351K Hold
4,723
0.03% 171
2020
Q4
$344K Hold
4,723
0.03% 165
2020
Q3
$314K Hold
4,723
0.03% 171
2020
Q2
$269K Buy
+4,723
New +$232K 0.03% 171
2018
Q1
Sell
-7,560
Closed -$323K 176
2017
Q4
$323K Buy
+7,560
New +$302K 0.04% 133

Other funds holding HOLX

Cannell & Spears's HOLX Position: Q1 2026 in Review

Cannell & Spears sold out of Hologic (HOLX) in Q1 2026, closing a stake of 3,452 shares — an estimated $257K sold.

Cannell & Spears first reported a position in HOLX in Q4 2017 and held it in 24 quarters. The position peaked at $351K in Q1 2021. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.

  • Cannell & Spears reported no remaining Hologic position as of Q1 2026 after selling out during the quarter.
  • Cannell & Spears sold 3,452 Hologic shares in Q1 2026, an estimated $257K.
  • Cannell & Spears first reported a position in Hologic in Q4 2017 and held it in 24 quarters.
  • Cannell & Spears's Hologic position peaked at $351K in Q1 2021.
  • 704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.

Based on Cannell & Spears's 13F filing for Q1 2026, filed 14 May 2026.